Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test

This document is a response to comments regarding the MolDX Breast Cancer Index® (BCI) gene expression test and does not itself state clinical coverage criteria. Coverage and clinical criteria are governed by MolDX Local Coverage Determination L37913, with notice beginning 2021-03-18 and effective date 2021-05-02; refer to L37913 for actionable indications, limitations, and documentation requirements.

"This document is a response to public comments and does not itself define clinical coverage criteria; coverage criteria for the Breast Cancer Index® (BCI) gene expression test are specified in MolD..."

Sign up to see full coverage criteria, indications, and limitations.